Abstract |
In 33 patients with primary ovarian cancer who had not received any chemotherapy before surgery, expression of glutathione S-transferase pi (GST-pi) was studied immunohistochemically in relation to the response to chemotherapy with CDDP, and furthermore it was examined whether numerical aberration of chromosome 11 was available as a prognostic indicator. The obtained results were as follows: 1. Of 33 ovarian cancer tissue samples, 19 (57.6%) showed positive staining and 14 (42.4%) negative staining for GST-pi. 2. The 5 year survival rate of the patients with GST-pi positive tumors was significantly lower than that of those with GST-pi negative tumors (p < 0.01). 3. The frequency of detection of cells showing numerical aberration of chromosome 11 in tissues was significantly higher in ovarian cancers than in benign ovarian tumors and normal ovaries. 4. The 5 year survival rate of the patients with ovarian cancer in which the cells showing numerical aberration of chromosome 11 at 20% or more was significantly lower than that of those in which such cells were under 20% (p < 0.02). These results show that expression of GST-pi and numerical aberration of chromosome 11 in the tissues of human ovarian cancers are useful as prognostic indicators.
|
Authors | Y Yokoyama, Y Fukushi, T Kunugi, H Maruyama, S Sato, Y Saito |
Journal | Nihon Sanka Fujinka Gakkai zasshi
(Nihon Sanka Fujinka Gakkai Zasshi)
Vol. 48
Issue 2
Pg. 118-24
(Feb 1996)
ISSN: 0300-9165 [Print] Japan |
PMID | 8718547
(Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Glutathione Transferase
- Cisplatin
|
Topics |
- Chromosome Aberrations
- Chromosomes, Human, Pair 11
- Cisplatin
(therapeutic use)
- Female
- Glutathione Transferase
(analysis)
- Humans
- Immunohistochemistry
- In Situ Hybridization
- Middle Aged
- Ovarian Neoplasms
(drug therapy, genetics, mortality)
- Prognosis
- Survival Rate
|